Julie A Hong

Chuong D. Hoang, M. Raffeld, W. Richards, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression

J. Wargo, S. Rosenberg, R. Morgan, 2009, Cancer Immunology, Immunotherapy.

Inhibition of histone lysine methylation enhances cancer-testis antigen expression in lung cancer cells: implications for adoptive immunotherapy of cancer.

R. Morgan, S. Xi, Julie A Hong, 2011, Cancer research.

Randomized phase II trial of a first-in-human cancer cell lysate vaccine in patients with thoracic malignancies

C. Hoang, Julie A Hong, Mary R. Zhang, 2021, Translational lung cancer research.

Inhibition of Histone Lysine Methylation Enhances Expression of Cancer-Testis Genes in Lung Cancer Cells: Implications for Adoptive Immunotherapy of Cancer

R. Morgan, S. Xi, Julie A Hong, 2011 .

FLASH Radiotherapy: New Technology Plus Biology Required.

C. N. Coleman, C. Coleman, C. Obcemea, 2021, International journal of radiation oncology, biology, physics.

Tumor Heterogeneity Research and Innovation in Biologically Based Radiation Therapy From the National Cancer Institute Radiation Research Program Portfolio.

C. N. Coleman, B. Vikram, C. Coleman, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes.

Victor V Lobanenkov, J. Barrett, D. Loukinov, 2005, Cancer research.

ASXL3 Is a Novel Pluripotency Factor in Human Respiratory Epithelial Cells and a Potential Therapeutic Target in Small Cell Lung Cancer.

S. Davis, Yonghong Wang, T. Ried, 2017, Cancer research.

Telomerase Variant A279T Induces Telomere Dysfunction and Inhibits Non-Canonical Telomerase Activity in Esophageal Carcinomas

D. Beer, C. Harris, B. Dumitriu, 2014, PloS one.

Utilization of Chromatin Remodeling Agents for Lung Cancer Therapy

Julie A Hong, D. Schrump, D. Nguyen, 2007, Cancer journal.

Depletion of DNA methyltransferase 1 and/or DNA methyltransferase 3b mediates growth arrest and apoptosis in lung and esophageal cancer and malignant pleural mesothelioma cells.

Julie A Hong, D. Schrump, D. Nguyen, 2006, The Journal of thoracic and cardiovascular surgery.

Cigarette Smoke Mediates Epigenetic Repression of miR-217 During Esophageal Adenocarcinogenesis

S. Steinberg, D. Beer, E. Bowman, 2015, Oncogene.

Clinical and Molecular Responses in Lung Cancer Patients Receiving Romidepsin

S. Steinberg, Julie A Hong, Tricia F. Kunst, 2007, Clinical Cancer Research.

Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.

Victor V Lobanenkov, J. Barrett, D. Loukinov, 2005, Cancer research.

Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells

R. Bueno, A. De Rienzo, Julie A Hong, 2015, Clinical Cancer Research.

Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer

W. Linehan, R. Srinivasan, M. Lerman, 2011, Oncogene.

Cigarette Smoke Induces C/EBP-β-Mediated Activation of miR-31 in Normal Human Respiratory Epithelia and Lung Cancer Cells

S. Xi, Hong Xu, J. Shan, 2010, PloS one.

Apoptosis Induced by Depsipeptide FK228 Coincides with Inhibition of Survival Signaling in Lung Cancer Cells

Julie A Hong, D. Schrump, D. Nguyen, 2007, Cancer journal.

ITGA1 is a pre-malignant biomarker that promotes therapy resistance and metastatic potential in pancreatic cancer

Julie A Hong, J. Kelber, Joy C. Lin, 2017, Scientific Reports.

Pulmonary Metastases Exhibit Epigenetic Clonality: Implications for Precision Cancer Therapy.

Julie A Hong, Mary R. Zhang, D. Schrump, 2015, The Annals of thoracic surgery.

The State of Preclinical Modeling for Early Phase Cancer Trials Using Molecularly Targeted Agents with Radiation

C. N. Coleman, B. Teicher, C. Obcemea, 2022, Radiation Research.

Mithramycin represses basal and cigarette smoke-induced expression of ABCG2 and inhibits stem cell signaling in lung and esophageal cancer cells.

S. Bates, H. Mani, S. Xi, 2012, Cancer research.

MithramycinRepressesBasalandCigaretteSmoke-Induced ExpressionofABCG2andInhibitsStemCellSignalinginLung and Esophageal Cancer Cells

S. Bates, S. Xi, Julie A Hong, 2012 .

Neutron Capture Therapy: The Promise of Novel Agents and Medical Facility-Based Neutron Sources.

C. N. Coleman, B. Vikram, Julie A Hong, 2023, Cancer biotherapy & radiopharmaceuticals.

ITGA1 is a pre-malignant biomarker that promotes therapy resistance and metastatic potential in pancreatic cancer

Julie A Hong, J. Kelber, Daniel Brambilla, 2017, Scientific Reports.

Severe Hepatotoxicity of Mithramycin Therapy Caused by Altered Expression of Hepatocellular Bile Transporters

D. Venzon, Julie A Hong, Mary R. Zhang, 2019, Molecular Pharmacology.

Analysis of circulating tumor DNA: The next paradigm shift in detection and treatment of lung cancer.

Julie A Hong, D. Schrump, 2018, The Journal of thoracic and cardiovascular surgery.

Induction of MAGE-3 expression in lung and esophageal cancer cells.

Julie A Hong, D. Schrump, D. Nguyen, 2001, The Annals of thoracic surgery.